| Date | Form | Description | Docs | XBRL | Pages |
| 04/15/22 | 8-K | Current report filing |
|
|
2 |
| 03/11/22 | 8-K | Current report filing |
|
|
13 |
| 03/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/11/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
19 |
| 01/28/22 | DEF 14A | Definitive proxy statements |
|
17 | |
| 01/13/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
Read More...Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
Read More...Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025
Read More...